Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Roche Goes To Glaxo Again: Marketing Head Abercrombie Is U.S. CEO

Executive Summary

Roche U.S. is turning to Glaxo for a new president in a repeat of the parent company's move six years ago to recruit new blood for Basel.

You may also be interested in...



Bush Medicare Plan Will Supplement State Rx Assistance, Thompson Says

The Bush Medicare plan will not interfere with state drug assistance programs, HHS Secretary Thompson testified before the House Ways & Means Committee hearing July 19.

Bush Medicare Plan Will Supplement State Rx Assistance, Thompson Says

The Bush Medicare plan will not interfere with state drug assistance programs, HHS Secretary Thompson testified before the House Ways & Means Committee hearing July 19.

Roche Pares Back To Specialty Care: U.S. Sales Force Will Be Cut By 24%

Roche will concentrate on specialty care products in the U.S. as part of the restructuring of its global pharmaceutical division.

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS037194

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel